Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.48 USD | +1.47% | +0.95% | -19.16% |
Jun. 07 | Geron shares surge after U.S. FDA approves blood disorder drug | RE |
Jun. 05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 42.34 | 47.84 | 51.93 |
Spread/Res. | -2.03% | -13.29% | -20.12% |
Spread/Supp. | +3.06% | +3.06% | +0.95% |
Support | 40.25 | 40.25 | 41.09 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- BMY Stock
- Charts Bristol-Myers Squibb Company